Potential involvement of serine/threonine protein phosphatases in apoptosis of HepG2 cells during selenite treatment

Biological Trace Element Research

Volumn 117, Issue 1-3, 2007, Pages 65-75

  Celik, Handan Ak ^a   Kircelli, Fatih ^a   Saydam, Guray ^a   Aydin, Hikmet Hakan ^a  

^a School of Medicine   (Turkey)

Author keywords

Apoptosis; HepG2 cells; PP1; PP2A; PP2B; PP2C; Selenium

Indexed keywords

CALCINEURIN; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE 2C; PROTEIN SERINE THREONINE KINASE; SELENITE; UNCLASSIFIED DRUG; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN SERINE THREONINE PHOSPHATASE; PROTEIN-SERINE-THREONINE PHOSPHATASE; SELENIUM; SODIUM SELENITE;

APOPTOSIS; ARTICLE; CELL DENSITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

EUKARYOTA; PROKARYOTA;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HUMANS; LIVER NEOPLASMS; PHOSPHOPROTEIN PHOSPHATASE; SELENIUM; SODIUM SELENITE;

EID: 35248894889     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02698084     Document Type: Article

References (35)

1. D. Medina et al., Selenium and mouse mammary tumorigenesis: an investigation of possible mechanisms, Cancer Res. 43(5 Suppl.), 2460-2464 (1983).
2. D. Medina and C. J. Oborn, Selenium inhibition of DNA synthesis in mouse mammary epithelial cell line YN-4, Cancer Res. 44, 4361-4365 (1984).
3. R. J. Shamberger, The genotoxicity of selenium, Mutat. Res. 154, 29-48 (1985).
4. M. Jacobs and C. Frost, Toxicological effects of sodium selenite in Sprague-Dawley rats, J Toxicol. Environ. Health 8, 575-585 (1981).
5. R. Gopalakrishna et al., Selenocompounds induce a redox modulation of protein kinase C in the cell, compartmentally independent from cytosolic glutathione: its role in inhibition of tumor promotion, Arch. Biochem. Biophys. 348, 37-48 (1997).
6. M. L. Handel et al., Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos, Proc. Natl. Acad. Sci. USA 92, 4497-4501 (1995).
7. I. Y. Kim and T. C. Stadtman, Inhibition of NF-kappaB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment, Proc. Natl. Acad. Sci. USA 94, 12,904-12,907 (1997).
8. H. S. Park, E. Park, M. S. Kim, et al., Selenite inhibits the c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) through a thiol redox mechanism, J. Biol. Chem. 275, 2527-2531 (2000).
9. G. Spyrou et al., AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione, FEBS Lett. 368, 59-63 (1995).
10. S. R. Stapleton et al., Selenium: potent stimulator of tyrosyl phosphorylation and activator of MAP kinase, Biochim. Biophys. Acta 1355, 259-269 (1997).
11. T. C. Stadtman, Selenocysteine, Annu. Rev. Biochem. 65, 83-100 (1996).
12. J. Lu et al., Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells, Biochem. Pharmacol. 47(9), 1531-1535 (1994).
13. J. Lanfear et al., The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis 15(7), 1387-1392 (1994).
14. Z. Zhu, M. Kimura, Y. Itokawa, et al., Apoptosis induced by selenium in human glioma cell lines, Biol. Trace Element Res. 54(2), 123-134 (1996).
15. R. Sinha and D. Medina, Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells, Carcinogenesis 18(8), 1541-1547 (1997).
16. C. Jiang et al., Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake, Mol. Carcinog. 26(4), 213-225 (1999).
17. R. Sinha, S. C. Kiley, J. X. Lu, et al., Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells, Cancer Lett. 146(2), 135-145 (1999).
18. H. S. Park, S. H. Huh, Y. Kim, et al., Selenite negatively regulates caspase-3 through a redox mechanism, J. Biol. Chem. 275(12), 8487-8491 (2000).
19. M. Chigbrow, M. Nelson, et al., Inhibition of mitotic cyclin B and cdc2 kinase activity by selenomethionine in synchronized colon cancer cells, Anticancer Drugs 12(1), 43-50 (2001).
20. C. Jiang et al., Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells, Cancer Res. 61(7), 3062-3070 (2001).
21. C. Jiang et al., Methyl selenium-induced vascular endothelial apoptosis is executed by caspases and principally mediated by p38 MAPK pathway, Nutr. Cancer 49(2), 174-183 (2004).
22. K. Yamaguchi, G. Uzzo, J. Pimkina, et al., Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis, Oncogene in press (2005).
23. M. B. Yin, Z. R. Li, S. Cao, et al., Enhanced 7-ethyl-10- hydroxycamptothecin (SN-38) lethality by methylselenocysteine is associated with Chk2 phosphorylation at threonine-68 and down-regulation of Cdc6 expression, Mol. Pharmacol. 66(1), 153-160 (2004).
24. G. F. Combs, Jr., Chemopreventive agents: selenium, Pharmacol. Ther. 79, 179-192 (1998).
25. H. A. Celik et al., Biochemical and morphological characteristics of selenite-induced apoptosis in human hepatoma Hep G2 cells, Biol. Trace Element Res. 99(1-3), 27-40 (2004).
26. K. Tachibana, P. J. Scheuer, Y. Tsukitani, et al., Okadaic acid, a cytotoxic polyether from two marine sponges of the genus Halichondria, J. Am. Chem. Soc. 103(9), 2469-2471 (1981).
27. A. Takai, C. Bialojan, M. Troschka, and J. C. Ruegg, Smooth muscle myosin phosphatase inhibition and force enhancement by black sponge toxin, FEBS Lett. 217(1), 81-84 (1987).
28. R. T. Boudreau, R. Garduno, and T. J. Lin, Protein phosphatase 2A and protein kinase C alpha are physically associated and are involved in Pseudomonas aeruginosa-induced interleukin 6 production by mast cells, J. Biol. Chem. 277(7), 5322-5329 (2002).
29. Y. Kato, N. Fusetani, S. Matsunaga, and K. Hashimoto, Calyculins, potent antitumour metabolites from the marine sponge Discodermia calyx: biological activities, Drugs Exp. Clin. Res. 14(12), 723-728 (1988).
30. H. Ishihara, B. L. Martin, D. L. Brautigan, et al., Calyculin Aand okadaic acid: inhibitors of protein phosphatase activity, Biochem. Biophys. Res. Commun. 159(3), 871-877 (1989).
31. P. Cohen, C. F. Holmes, and Y. Tsukitani, Okadaic acid: a new probe for the study of cellular regulation, Trends Biochem. Sci. 15(3), 98-102 (1990).
32. J. M. Sargent, The use of the MTT assay to study drug resistance in fresh tumour samples, Recent Results Cancer Res. 161, 13-25 (2003).
33. B. G. Neil and N. K. Tonks, Protein tyrosine phosphatates in signal transduction, Curr. Opin. Cell Biol. 9, 193-204 (1997).
34. X. Lu et al., PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints, Genes Dev. 19(10), 1162-1174 (2005).
35. S. St Clair, L. Giono, S. Varmeh Ziaie, et al., DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter, Mol. Cell 16(5), 725-736 (2004).